Kwang K. Koh

Report on the Joint Symposium of the Korean Society of CardioMetabolic Syndrome (KSCMS) and the Japanese Society of Hypertension (JSH) at the 8th Asia-Pacific CardioMetabolic Syndrome (APCMS) Congress in Seoul.

Journal: Hypertension research : official journal of the Japanese Society of Hypertension

Published: June 13, 2025

Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients.

Journal: Journal of lipid research

Published: April 18, 2025

Sex-specific impact of the COVID-19 outbreak on the incidence of metabolic syndrome: a comparative study of 2018-2019 and 2020-2021.

Journal: The Korean journal of internal medicine

Published: October 15, 2024

Metabolic syndrome awareness in the general Korean population: results from a nationwide survey.

Journal: The Korean journal of internal medicine

Published: August 27, 2023

Which biomarker to use, when to start, and how to improve adherence for reducing atherosclerotic cardiovascular disease risk?

Journal: European heart journal

Published: December 22, 2020

Adiponectin and cardiometabolic trait and mortality: where do we go?

Journal: Cardiovascular research

Published: November 27, 2020

New Trends in Dyslipidemia Treatment.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: November 12, 2020

Association of pericardial adipose tissue with left ventricular structure and function: a region-specific effect?

Journal: Cardiovascular diabetology

Published: September 23, 2020

Lipoprotein(a) and Cardiovascular Diseases　- Revisited.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: April 28, 2020

Cardiovascular effects of omega-3 fatty acids: Hope or hype?

Journal: Atherosclerosis

Published: January 18, 2020

Strategies to Overcome Residual Risk During Statins Era.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: August 09, 2019

Importance of Risk Stratification After Myocardial Infarction and the Need for Its Clinical Application.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 01, 2019

Report on the Joint Symposium of the Korean Society of CardioMetabolic Syndrome (KSCMS) and the Japanese Society of Hypertension (JSH) at the 8th Asia-Pacific CardioMetabolic Syndrome (APCMS) Congress in Seoul.

Report on the Joint Symposium of the Korean Society of CardioMetabolic Syndrome (KSCMS) and the Japanese Society of Hypertension (JSH) at the 8th Asia-Pacific CardioMetabolic Syndrome (APCMS) Congress in Seoul.

Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients.

Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients.

Sex-specific impact of the COVID-19 outbreak on the incidence of metabolic syndrome: a comparative study of 2018-2019 and 2020-2021.

Sex-specific impact of the COVID-19 outbreak on the incidence of metabolic syndrome: a comparative study of 2018-2019 and 2020-2021.

Metabolic syndrome awareness in the general Korean population: results from a nationwide survey.

Metabolic syndrome awareness in the general Korean population: results from a nationwide survey.

Which biomarker to use, when to start, and how to improve adherence for reducing atherosclerotic cardiovascular disease risk?

Which biomarker to use, when to start, and how to improve adherence for reducing atherosclerotic cardiovascular disease risk?

Adiponectin and cardiometabolic trait and mortality: where do we go?

Adiponectin and cardiometabolic trait and mortality: where do we go?

New Trends in Dyslipidemia Treatment.

New Trends in Dyslipidemia Treatment.

Association of pericardial adipose tissue with left ventricular structure and function: a region-specific effect?

Association of pericardial adipose tissue with left ventricular structure and function: a region-specific effect?

Lipoprotein(a) and Cardiovascular Diseases - Revisited.

Lipoprotein(a) and Cardiovascular Diseases - Revisited.

Cardiovascular effects of omega-3 fatty acids: Hope or hype?

Cardiovascular effects of omega-3 fatty acids: Hope or hype?

Strategies to Overcome Residual Risk During Statins Era.

Strategies to Overcome Residual Risk During Statins Era.

Importance of Risk Stratification After Myocardial Infarction and the Need for Its Clinical Application.

Importance of Risk Stratification After Myocardial Infarction and the Need for Its Clinical Application.

Lipoprotein(a) and Cardiovascular Diseases　- Revisited.

Lipoprotein(a) and Cardiovascular Diseases　- Revisited.